Menu

Stronger Neural Connections May Trump Genetic Risk for Bipolar Disorder

Healthy siblings of people with the condition harbor more cohesive connections within certain brain networks.

Nov 1, 2017
Aggie Mika

FAMILY RESEMBLANCE: A new study reveals clues to how most siblings of people with bipolar avoid the disease.© ISTOCK.COM/IMRSQUID

EDITOR'S CHOICE IN NEUROSCIENCE

The paper
G.E. Doucet et al., “The role of intrinsic brain functional connectivity in vulnerability and resilience to bipolar disorder,” Am J Psychiat, doi:10.1176/appi.ajp.2017.17010095, 2017.

Ties that don’t bind
Bipolar disorder often runs in families, but genetics alone don’t determine whether one develops the disease, says Sophia Frangou of the Icahn School of Medicine at Mount Sinai. She and her colleagues wondered why siblings of affected people, despite having a slightly higher chance of developing mental illness, typically don’t.

In sync
Using fMRI, Frangou’s group previously found that, compared with the brains of bipolar patients, certain regions within healthy siblings’ brains responded more synchronously during memory and emotional processing tasks. To find out whether this reflects differences in brain organization, postdoc Gaelle Doucet imaged 78 people with bipolar disorder, 64 of their unaffected siblings, and 41 healthy, unrelated controls, all while they were doing nothing.

Compensatory connections
The sensorimotor network, which is important for integrating sensation and movement, was poorly connected in both bipolar patients and their healthy siblings compared with the control group. But, Frangou says, healthy siblings demonstrated stronger connections even than controls within the default mode network, “the backbone of the brain,” which contributes to recall and self-reflection—activities unrelated to specific tasks. It’s possible that the default mode network is “stepping up . . . and somehow regulating the sensorimotor network,” says Ellen Leibenluft of the National Institute of Mental Health.

Little to do with luck
Frangou emphasizes that avoiding disease is a matter of adaptive neural mechanisms. “We have to stop thinking about why people become unwell and question why people who have all the risks to become unwell stay well,” she says.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.